The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Terlipressin Market Research Report 2025
Synopsis
Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
The global Terlipressin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Terlipressin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Terlipressin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Terlipressin include EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi 'an langene biological technology, SGPharma, Maya Biotech and Hangzhou Huadi Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Terlipressin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terlipressin.
Report Scope
The Terlipressin market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terlipressin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terlipressin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EVER Pharma
Hybio Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Shanghai Soho-Yiming Pharmaceuticals
Xi 'an langene biological technology
SGPharma
Maya Biotech
Hangzhou Huadi Group
Segment by Type
5ml vial Injections
10mL vial Injections
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terlipressin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terlipressin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
The global Terlipressin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Terlipressin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Terlipressin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Terlipressin include EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi 'an langene biological technology, SGPharma, Maya Biotech and Hangzhou Huadi Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Terlipressin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terlipressin.
Report Scope
The Terlipressin market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terlipressin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terlipressin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
EVER Pharma
Hybio Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Shanghai Soho-Yiming Pharmaceuticals
Xi 'an langene biological technology
SGPharma
Maya Biotech
Hangzhou Huadi Group
Segment by Type
5ml vial Injections
10mL vial Injections
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terlipressin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terlipressin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Terlipressin Market Overview
1.1 Product Overview and Scope of Terlipressin
1.2 Terlipressin Segment by Type
1.2.1 Global Terlipressin Market Value Comparison by Type (2024-2030)
1.2.2 5ml vial Injections
1.2.3 10mL vial Injections
1.3 Terlipressin Segment by Application
1.3.1 Global Terlipressin Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Terlipressin Market Size Estimates and Forecasts
1.4.1 Global Terlipressin Revenue 2019-2030
1.4.2 Global Terlipressin Sales 2019-2030
1.4.3 Global Terlipressin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Terlipressin Market Competition by Manufacturers
2.1 Global Terlipressin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Terlipressin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Terlipressin Average Price by Manufacturers (2019-2024)
2.4 Global Terlipressin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terlipressin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terlipressin, Product Type & Application
2.7 Terlipressin Market Competitive Situation and Trends
2.7.1 Terlipressin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terlipressin Players Market Share by Revenue
2.7.3 Global Terlipressin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terlipressin Retrospective Market Scenario by Region
3.1 Global Terlipressin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Terlipressin Global Terlipressin Sales by Region: 2019-2030
3.2.1 Global Terlipressin Sales by Region: 2019-2024
3.2.2 Global Terlipressin Sales by Region: 2025-2030
3.3 Global Terlipressin Global Terlipressin Revenue by Region: 2019-2030
3.3.1 Global Terlipressin Revenue by Region: 2019-2024
3.3.2 Global Terlipressin Revenue by Region: 2025-2030
3.4 North America Terlipressin Market Facts & Figures by Country
3.4.1 North America Terlipressin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Terlipressin Sales by Country (2019-2030)
3.4.3 North America Terlipressin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terlipressin Market Facts & Figures by Country
3.5.1 Europe Terlipressin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Terlipressin Sales by Country (2019-2030)
3.5.3 Europe Terlipressin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terlipressin Market Facts & Figures by Country
3.6.1 Asia Pacific Terlipressin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Terlipressin Sales by Country (2019-2030)
3.6.3 Asia Pacific Terlipressin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terlipressin Market Facts & Figures by Country
3.7.1 Latin America Terlipressin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Terlipressin Sales by Country (2019-2030)
3.7.3 Latin America Terlipressin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terlipressin Market Facts & Figures by Country
3.8.1 Middle East and Africa Terlipressin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Terlipressin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Terlipressin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Terlipressin Sales by Type (2019-2030)
4.1.1 Global Terlipressin Sales by Type (2019-2024)
4.1.2 Global Terlipressin Sales by Type (2025-2030)
4.1.3 Global Terlipressin Sales Market Share by Type (2019-2030)
4.2 Global Terlipressin Revenue by Type (2019-2030)
4.2.1 Global Terlipressin Revenue by Type (2019-2024)
4.2.2 Global Terlipressin Revenue by Type (2025-2030)
4.2.3 Global Terlipressin Revenue Market Share by Type (2019-2030)
4.3 Global Terlipressin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Terlipressin Sales by Application (2019-2030)
5.1.1 Global Terlipressin Sales by Application (2019-2024)
5.1.2 Global Terlipressin Sales by Application (2025-2030)
5.1.3 Global Terlipressin Sales Market Share by Application (2019-2030)
5.2 Global Terlipressin Revenue by Application (2019-2030)
5.2.1 Global Terlipressin Revenue by Application (2019-2024)
5.2.2 Global Terlipressin Revenue by Application (2025-2030)
5.2.3 Global Terlipressin Revenue Market Share by Application (2019-2030)
5.3 Global Terlipressin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 EVER Pharma
6.1.1 EVER Pharma Corporation Information
6.1.2 EVER Pharma Description and Business Overview
6.1.3 EVER Pharma Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 EVER Pharma Terlipressin Product Portfolio
6.1.5 EVER Pharma Recent Developments/Updates
6.2 Hybio Pharmaceutical
6.2.1 Hybio Pharmaceutical Corporation Information
6.2.2 Hybio Pharmaceutical Description and Business Overview
6.2.3 Hybio Pharmaceutical Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hybio Pharmaceutical Terlipressin Product Portfolio
6.2.5 Hybio Pharmaceutical Recent Developments/Updates
6.3 Sun Pharmaceutical Industries Ltd.
6.3.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.3.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.3.3 Sun Pharmaceutical Industries Ltd. Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Industries Ltd. Terlipressin Product Portfolio
6.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.4 Shanghai Soho-Yiming Pharmaceuticals
6.4.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
6.4.2 Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
6.4.3 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Soho-Yiming Pharmaceuticals Terlipressin Product Portfolio
6.4.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
6.5 Xi 'an langene biological technology
6.5.1 Xi 'an langene biological technology Corporation Information
6.5.2 Xi 'an langene biological technology Description and Business Overview
6.5.3 Xi 'an langene biological technology Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Xi 'an langene biological technology Terlipressin Product Portfolio
6.5.5 Xi 'an langene biological technology Recent Developments/Updates
6.6 SGPharma
6.6.1 SGPharma Corporation Information
6.6.2 SGPharma Description and Business Overview
6.6.3 SGPharma Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SGPharma Terlipressin Product Portfolio
6.6.5 SGPharma Recent Developments/Updates
6.7 Maya Biotech
6.6.1 Maya Biotech Corporation Information
6.6.2 Maya Biotech Description and Business Overview
6.6.3 Maya Biotech Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Maya Biotech Terlipressin Product Portfolio
6.7.5 Maya Biotech Recent Developments/Updates
6.8 Hangzhou Huadi Group
6.8.1 Hangzhou Huadi Group Corporation Information
6.8.2 Hangzhou Huadi Group Description and Business Overview
6.8.3 Hangzhou Huadi Group Terlipressin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hangzhou Huadi Group Terlipressin Product Portfolio
6.8.5 Hangzhou Huadi Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terlipressin Industry Chain Analysis
7.2 Terlipressin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terlipressin Production Mode & Process
7.4 Terlipressin Sales and Marketing
7.4.1 Terlipressin Sales Channels
7.4.2 Terlipressin Distributors
7.5 Terlipressin Customers
8 Terlipressin Market Dynamics
8.1 Terlipressin Industry Trends
8.2 Terlipressin Market Drivers
8.3 Terlipressin Market Challenges
8.4 Terlipressin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Terlipressin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Terlipressin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Terlipressin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Terlipressin Sales (K Vials) of Key Manufacturers (2019-2024)
Table 5. Global Terlipressin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Terlipressin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Terlipressin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Terlipressin Average Price (USD/Vial) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Terlipressin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Terlipressin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Terlipressin, Product Type & Application
Table 12. Global Key Manufacturers of Terlipressin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Terlipressin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terlipressin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Terlipressin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Terlipressin Sales by Region (2019-2024) & (K Vials)
Table 18. Global Terlipressin Sales Market Share by Region (2019-2024)
Table 19. Global Terlipressin Sales by Region (2025-2030) & (K Vials)
Table 20. Global Terlipressin Sales Market Share by Region (2025-2030)
Table 21. Global Terlipressin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Terlipressin Revenue Market Share by Region (2019-2024)
Table 23. Global Terlipressin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Terlipressin Revenue Market Share by Region (2025-2030)
Table 25. North America Terlipressin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Terlipressin Sales by Country (2019-2024) & (K Vials)
Table 27. North America Terlipressin Sales by Country (2025-2030) & (K Vials)
Table 28. North America Terlipressin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Terlipressin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Terlipressin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Terlipressin Sales by Country (2019-2024) & (K Vials)
Table 32. Europe Terlipressin Sales by Country (2025-2030) & (K Vials)
Table 33. Europe Terlipressin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Terlipressin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Terlipressin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Terlipressin Sales by Region (2019-2024) & (K Vials)
Table 37. Asia Pacific Terlipressin Sales by Region (2025-2030) & (K Vials)
Table 38. Asia Pacific Terlipressin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Terlipressin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Terlipressin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Terlipressin Sales by Country (2019-2024) & (K Vials)
Table 42. Latin America Terlipressin Sales by Country (2025-2030) & (K Vials)
Table 43. Latin America Terlipressin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Terlipressin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Terlipressin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Terlipressin Sales by Country (2019-2024) & (K Vials)
Table 47. Middle East & Africa Terlipressin Sales by Country (2025-2030) & (K Vials)
Table 48. Middle East & Africa Terlipressin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Terlipressin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Terlipressin Sales (K Vials) by Type (2019-2024)
Table 51. Global Terlipressin Sales (K Vials) by Type (2025-2030)
Table 52. Global Terlipressin Sales Market Share by Type (2019-2024)
Table 53. Global Terlipressin Sales Market Share by Type (2025-2030)
Table 54. Global Terlipressin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Terlipressin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Terlipressin Revenue Market Share by Type (2019-2024)
Table 57. Global Terlipressin Revenue Market Share by Type (2025-2030)
Table 58. Global Terlipressin Price (USD/Vial) by Type (2019-2024)
Table 59. Global Terlipressin Price (USD/Vial) by Type (2025-2030)
Table 60. Global Terlipressin Sales (K Vials) by Application (2019-2024)
Table 61. Global Terlipressin Sales (K Vials) by Application (2025-2030)
Table 62. Global Terlipressin Sales Market Share by Application (2019-2024)
Table 63. Global Terlipressin Sales Market Share by Application (2025-2030)
Table 64. Global Terlipressin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Terlipressin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Terlipressin Revenue Market Share by Application (2019-2024)
Table 67. Global Terlipressin Revenue Market Share by Application (2025-2030)
Table 68. Global Terlipressin Price (USD/Vial) by Application (2019-2024)
Table 69. Global Terlipressin Price (USD/Vial) by Application (2025-2030)
Table 70. EVER Pharma Corporation Information
Table 71. EVER Pharma Description and Business Overview
Table 72. EVER Pharma Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 73. EVER Pharma Terlipressin Product
Table 74. EVER Pharma Recent Developments/Updates
Table 75. Hybio Pharmaceutical Corporation Information
Table 76. Hybio Pharmaceutical Description and Business Overview
Table 77. Hybio Pharmaceutical Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 78. Hybio Pharmaceutical Terlipressin Product
Table 79. Hybio Pharmaceutical Recent Developments/Updates
Table 80. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 81. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 82. Sun Pharmaceutical Industries Ltd. Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 83. Sun Pharmaceutical Industries Ltd. Terlipressin Product
Table 84. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 85. Shanghai Soho-Yiming Pharmaceuticals Corporation Information
Table 86. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 87. Shanghai Soho-Yiming Pharmaceuticals Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 88. Shanghai Soho-Yiming Pharmaceuticals Terlipressin Product
Table 89. Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
Table 90. Xi 'an langene biological technology Corporation Information
Table 91. Xi 'an langene biological technology Description and Business Overview
Table 92. Xi 'an langene biological technology Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 93. Xi 'an langene biological technology Terlipressin Product
Table 94. Xi 'an langene biological technology Recent Developments/Updates
Table 95. SGPharma Corporation Information
Table 96. SGPharma Description and Business Overview
Table 97. SGPharma Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 98. SGPharma Terlipressin Product
Table 99. SGPharma Recent Developments/Updates
Table 100. Maya Biotech Corporation Information
Table 101. Maya Biotech Description and Business Overview
Table 102. Maya Biotech Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 103. Maya Biotech Terlipressin Product
Table 104. Maya Biotech Recent Developments/Updates
Table 105. Hangzhou Huadi Group Corporation Information
Table 106. Hangzhou Huadi Group Description and Business Overview
Table 107. Hangzhou Huadi Group Terlipressin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 108. Hangzhou Huadi Group Terlipressin Product
Table 109. Hangzhou Huadi Group Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Terlipressin Distributors List
Table 113. Terlipressin Customers List
Table 114. Terlipressin Market Trends
Table 115. Terlipressin Market Drivers
Table 116. Terlipressin Market Challenges
Table 117. Terlipressin Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Terlipressin
Figure 2. Global Terlipressin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Terlipressin Market Share by Type in 2023 & 2030
Figure 4. 5ml vial Injections Product Picture
Figure 5. 10mL vial Injections Product Picture
Figure 6. Global Terlipressin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Terlipressin Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Terlipressin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Terlipressin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Terlipressin Sales (2019-2030) & (K Vials)
Figure 14. Global Terlipressin Average Price (USD/Vial) & (2019-2030)
Figure 15. Terlipressin Report Years Considered
Figure 16. Terlipressin Sales Share by Manufacturers in 2023
Figure 17. Global Terlipressin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Terlipressin Players: Market Share by Revenue in 2023
Figure 19. Terlipressin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Terlipressin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Terlipressin Sales Market Share by Country (2019-2030)
Figure 22. North America Terlipressin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Terlipressin Sales Market Share by Country (2019-2030)
Figure 26. Europe Terlipressin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Terlipressin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Terlipressin Revenue Market Share by Region (2019-2030)
Figure 34. China Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Terlipressin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Terlipressin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Terlipressin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Terlipressin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Terlipressin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Terlipressin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Terlipressin by Type (2019-2030)
Figure 56. Global Terlipressin Price (USD/Vial) by Type (2019-2030)
Figure 57. Global Sales Market Share of Terlipressin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Terlipressin by Application (2019-2030)
Figure 59. Global Terlipressin Price (USD/Vial) by Application (2019-2030)
Figure 60. Terlipressin Value Chain
Figure 61. Terlipressin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
